Search - tctmd.com

Displaying 1 - 2 of 2

Sort: Relevancy | Date

Presentation AHA 2018

Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial

Presenter: Sotirios Tsimikas

November 11, 2018

Presentation AHA 2017

Presenter: Mar Pujades-Rodriguez

November 14, 2017

Country

First Name

Last Name

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.